Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases

BACKGROUND: Bevacizumab, an anti–vascular endothelial growth factor antibody, has been used for the treatment of radiation necrosis. Thus far, however, there has been no definitive report on its use for the treatment of symptomatic pseudoprogression. Here we report 2 cases of successful treatment wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Miyatake, Shin-Ichi, Furuse, Motomasa, Kawabata, Shinji, Maruyama, Takashi, Kumabe, Toshihiro, Kuroiwa, Toshihiko, Ono, Koji
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2013
Schlagworte:
Case Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661101/
https://ncbi.nlm.nih.gov/pubmed/23460324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not020
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge